Dr. Mohammad Saad Yazdanie, MD

Dr. Yazdanie practices at Coastal Eye Associates in Webster, Texas.

Dr. Yazdanie's NPI, 1467949933, was assigned on April 19, 2018. Dr. Yazdanie graduated from Renaissance School of Medicine at Stony Brook University in 2018. Dr. Yazdanie holds Texas license T6419.

Dr. Yazdanie's primary practice is Coastal Eye Associates, at 555 E Medical Center Blvd, Webster, TX 77598 in Harris County. The practice phone is (281) 488-7213.

Dr. Yazdanie's primary practice is Coastal Eye Associates in Webster, Texas. Dmand AI also links Dr. Yazdanie to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yazdanie practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Yazdanie's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Yazdanie is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Yazdanie is licensed in Texas.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation and eyelid inflammation among the conditions Dr. Yazdanie treats.

CMS data shows 1,794 Medicare services from Dr. Yazdanie across 17 procedure codes in 2024, for 658 Medicare patients. Medicare paid $208,304 for them.

CMS counts 658 Medicare patients who saw Dr. Yazdanie in 2024. The largest group is 65 to 74, with 309 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.24, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Yazdanie's median patient age at 72, with 60% women.

In 2024, Dr. Yazdanie wrote 2,235 Medicare Part D claims for 802 patients. 65% of them were for generic drugs. CMS names the drug for 2,167 of them, across 20 drugs with 11 or more claims each, at $239,368 in total drug cost. In 2023, CMS named 1,277 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Yazdanie for performance year 2024, reported individually. Dr. Yazdanie accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 277 procedures of cataract surgery by Dr. Yazdanie, more than 88% of the clinicians it reports for that procedure.

Dmand AI links 6 papers to Dr. Yazdanie, published from 2017 to 2020. 2017 was the busiest year, with 2. The most frequent topics are Dark Adaptation, Macular Degeneration and Visual Acuity. Dr. Yazdanie has published most often in Ophthalmology. Dr. Yazdanie's most frequent co-authors are Khurram Mahmood Chaudhary, MD, Azin Abazari, MD and Katherine Grace Chen, MS.

CMS Open Payments shows 80 general payments to Dr. Yazdanie from 16 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 99% of the total. Abbvie Inc. paid the most, $810.

Dmand AI lists 2 awards for Dr. Yazdanie, most recently Alpha Omega Alpha in 2017.

Dr. Yazdanie graduated from Renaissance School of Medicine at Stony Brook University in 2018.

Dr. Yazdanie is in network with 20 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.